We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong income characteristics for investors to consider today, October 22nd:
Sunoco LP (SUN - Free Report) : This distributor and retailer of motor fuels has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 13.29%, compared with the industry average of 12.83%. Its five-year average dividend yield is 11.39%.
Lazard Ltd (LAZ - Free Report) : This financial advisory and asset management firm has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.8% over the last 60 days.
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 5.21%, compared with the industry average of 1.84%. Its five-year average dividend yield is 4.34%.
Franklin Resources, Inc. (BEN - Free Report) : This asset management holding company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.3% over the last 60 days.
This Zacks Rank #2 (Buy) company has a dividend yield of 4.75%, compared with the industry average of 1.84%. Its five-year average dividend yield is 2.9%.
AllianceBernstein Holding L.P. (AB - Free Report) : This investment managerhas witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% over the last 60 days.
AllianceBernstein Holding L.P. Price and Consensus
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Income Stocks to Buy for October 22nd
Here are four stocks with buy rank and strong income characteristics for investors to consider today, October 22nd:
Sunoco LP (SUN - Free Report) : This distributor and retailer of motor fuels has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
Sunoco LP Price and Consensus
Sunoco LP price-consensus-chart | Sunoco LP Quote
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 13.29%, compared with the industry average of 12.83%. Its five-year average dividend yield is 11.39%.
Sunoco LP Dividend Yield (TTM)
Sunoco LP dividend-yield-ttm | Sunoco LP Quote
Lazard Ltd (LAZ - Free Report) : This financial advisory and asset management firm has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.8% over the last 60 days.
Lazard Ltd Price and Consensus
Lazard Ltd price-consensus-chart | Lazard Ltd Quote
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 5.21%, compared with the industry average of 1.84%. Its five-year average dividend yield is 4.34%.
Lazard Ltd Dividend Yield (TTM)
Lazard Ltd dividend-yield-ttm | Lazard Ltd Quote
Franklin Resources, Inc. (BEN - Free Report) : This asset management holding company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.3% over the last 60 days.
Franklin Resources, Inc. Price and Consensus
Franklin Resources, Inc. price-consensus-chart | Franklin Resources, Inc. Quote
This Zacks Rank #2 (Buy) company has a dividend yield of 4.75%, compared with the industry average of 1.84%. Its five-year average dividend yield is 2.9%.
Franklin Resources, Inc. Dividend Yield (TTM)
Franklin Resources, Inc. dividend-yield-ttm | Franklin Resources, Inc. Quote
AllianceBernstein Holding L.P. (AB - Free Report) : This investment managerhas witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% over the last 60 days.
AllianceBernstein Holding L.P. Price and Consensus
AllianceBernstein Holding L.P. price-consensus-chart | AllianceBernstein Holding L.P. Quote
This Zacks Rank #2 company has a dividend yield of 7.55%, compared with the industry average of 1.84%. Its five-year average dividend yield is 8.9%.
AllianceBernstein Holding L.P. Dividend Yield (TTM)
AllianceBernstein Holding L.P. dividend-yield-ttm | AllianceBernstein Holding L.P. Quote
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>